Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for 4th Quarter ended March 31, 2026 of FY 2025-26.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Amwill Health Care Ltd has filed a compliance certificate with BSE confirming adherence to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ending March 31, 2026. Regulation 74(5) requires depositories to certify that all securities received from issuers have been dematerialised and intimated to the relevant issuer within the stipulated timeframe. This is a routine regulatory filing as part of the company's quarterly compliance obligations. The filing indicates the company has met its statutory reporting requirement for Q4 of FY 2025-26.
No material impact on stock price. This is a standard regulatory compliance filing confirming the company is in good standing with SEBI depository norms. It reflects adherence to mandatory governance requirements.